Archer, David F.

2021

Drospirenone Effects on the Plasminogen Activator System in Immortalized Human Endometrial Endothelial Cells. REPRODUCTIVE SCIENCES.

Full Text via DOI: 10.1007/s43032-020-00433-x PMID: 33559058

2021

Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix. JOURNAL OF PAIN RESEARCH. 14:263-271.

Full Text via DOI: 10.2147/JPR.S284703 PMID: 33564263

2021

Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 224.

Full Text via DOI: 10.1016/j.ajog.2020.07.032 PMID: 32702363

2020

A pilot study: estradiol/progesterone effect on cervico-vaginal cytokines in premenopause and postmenopause. CLIMACTERIC. 23:306-310.

Full Text via DOI: 10.1080/13697137.2020.1727878 PMID: 32107942

2020

Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids. NEW ENGLAND JOURNAL OF MEDICINE. 382:328-340.

Full Text via DOI: 10.1056/NEJMoa1904351 PMID: 31971678

2020

Endometrial safety and bleeding profile of a 17β-estradiol/progesterone oral softgel capsule (TX-001HR).. Menopause (New York, N.Y.). 410-417.

Full Text via DOI: 10.1097/GME.0000000000001480 PMID: 31913228

2020

Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate. CONTRACEPTION. 102:168-173.

Full Text via DOI: 10.1016/j.contraception.2020.05.004

2019

Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain. JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS. 11:171-180.

Full Text via DOI: 10.1177/2284026519872401

2019

TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women. CLIMACTERIC. 22:412-418.

Full Text via DOI: 10.1080/13697137.2019.1577379 PMID: 30862193

2019

A combined, bioidentical, oral, 17 beta-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause. EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 12:729-739.

Full Text via DOI: 10.1080/17512433.2019.1637731 PMID: 31282768

2019

Comparison of self-reported female condom failure and biomarker-confirmed semen exposure. CONTRACEPTION. 100:406-412.

Full Text via DOI: 10.1016/j.contraception.2019.07.143 PMID: 31381878

2019

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 26:611-621.

Full Text via DOI: 10.1097/GME.0000000000001292 PMID: 30694917

2019

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials. LANCET GLOBAL HEALTH. 7:E1054-E1064.

Full Text via DOI: 10.1016/S2214-109X(19)30265-7 PMID: 31231065

2019

Elagolix suppresses ovulation in a dose-dependent manner: Results from a 3-month, randomized study in ovulatory women.. The Journal of clinical endocrinology and metabolism.

Full Text via DOI: 10.1210/clinem/dgz086 PMID: 31650182

2019

Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM. 14:301-314.

Full Text via DOI: 10.1080/17446651.2019.1657008 PMID: 31526199

2018

Estradiol vaginal inserts (4 mu g and 10 mu g) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic data. CURRENT MEDICAL RESEARCH AND OPINION. 2131-2136.

Full Text via DOI: 10.1080/03007995.2018.1527578 PMID: 30238814

2018

Effects of Single-Capsule 17 beta-Estradiol/Progesterone (TX-001HR) on Weight and Blood Pressure in Menopausal Women of the REPLENISH Trial. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1496-1497.

2018

Efficacy and Safety of Ospemifene in Menopausal Women with Moderate to Severe Vaginal Dryness: A phase 3, Randomized Double-Blind Placebo-Controlled Multicenter Clinical Trial. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1501-1501.

2018

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas A Randomized Controlled Trial. OBSTETRICS AND GYNECOLOGY. 132:1252-1264.

Full Text via DOI: 10.1097/AOG.0000000000002933 PMID: 30303923

2018

Safety and efficacy results for the segesterone acetate ethinyl estradiol (SA/EE) contraceptive vaginal ring. CONTRACEPTION. 336-336.

Full Text via DOI: 10.1016/j.contraception.2018.07.024

2018

BONE TURNOVER CHANGES IN WOMEN TREATED WITH ELAGOLIX OR PLACEBO DURING THE ELARIS EM-I AND EM-II TRIALS WHO DID NOT CONTINUE IN THE EXTENSION STUDIES.. FERTILITY AND STERILITY. E12-E12.

2018

EFFECT OF ORAL ESTRADIOL AND PROGESTERONE THERAPY ON VAGINAL CYTOKINES IN POSTMENOPAUSAL WOMEN.. FERTILITY AND STERILITY. E286-E286.

2018

ELAGOLIX REDUCED DYSPAREUNIA AND IMPROVED HEALTH-RELATED QUALITY OF LIFE IN PREMENOPAUSAL WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN.. FERTILITY AND STERILITY. E82-E83.

2018

ESTRADIOL LEVELS ARE DIFFERENTIALLY SUPPRESSED BY ELAGOLIX COMPARED TO LEUPROLIDE ACETATE.. FERTILITY AND STERILITY. E12-E13.

2018

Morbid obesity: potential effects of hormonal contraception. CONTRACEPTION. 174-180.

Full Text via DOI: 10.1016/j.contraception.2018.05.008 PMID: 29777662

2018

Untitled. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 952-953.

2018

A 17 beta-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women. OBSTETRICS AND GYNECOLOGY. 132:161-170.

Full Text via DOI: 10.1097/AOG.0000000000002645 PMID: 29889748

2018

Long-Term Outcomes of Elagolix in Women With Endometriosis. OBSTETRICS AND GYNECOLOGY. 132:147-160.

Full Text via DOI: 10.1097/AOG.0000000000002675 PMID: 29889764

2018

The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 837-847.

Full Text via DOI: 10.1097/GME.0000000000001138 PMID: 29870471

2018

Vaginal pH: a simple assessment highly correlated with vaginal morphology and symptoms in postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 25:762-766.

Full Text via DOI: 10.1097/GME.0000000000001081 PMID: 29509598

2018

Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone (R) and estradiol: pharmacokinetics from a dose-finding study. CONTRACEPTION. 97:422-427.

Full Text via DOI: 10.1016/j.contraception.2018.01.012 PMID: 29409834

2018

Long-term Effect of Elagolix on Bone Mineral Density in Women with Endometriosis-Associated Pain. OBSTETRICS AND GYNECOLOGY. 86S-87S.

Full Text via DOI: 10.1097/01.AOG.0000533387.12236.72

2018

A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 25:133-138.

Full Text via DOI: 10.1097/GME.0000000000000985 PMID: 28926514

2018

Doxycycline Alters the Expression of Matrix Metalloproteases in the Endometrial Cells Exposed to Ovarian Steroids and Pro-inflammatory Cytokine (Retraction of Vol 73, Pg 118, 2017). JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 106-106.

Full Text via DOI: 10.1016/j.jri.2017.11.002 PMID: 29406209

2018

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 25:1339-1353.

Full Text via DOI: 10.1097/GME.0000000000001238 PMID: 30358731

2018

Human vaginal pH and microbiota: an update. GYNECOLOGICAL ENDOCRINOLOGY. 34:451-455.

Full Text via DOI: 10.1080/09513590.2017.1407753 PMID: 29271266

2018

Untitled. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 952-953.

Full Text via DOI: 10.1097/GME.0000000000001146 PMID: 29944639

2017

17 beta-Estradiol/Progesterone in a Single Oral Softgel Capsule (TX-001HR) Significantly Reduced Moderate-to-Severe Vasomotor Symptoms without Endometrial Hyperplasia. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1430-+.

2017

A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom. JOURNAL OF WOMENS HEALTH. 27:231-237.

Full Text via DOI: 10.1089/jwh.2017.6515 PMID: 29193980

2017

Concerns with Long-Term Estrogen Exposure, Inconsistent Treatment Use, and Reduced Quality of Life in Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1445-1446.

2017

Effects of TX-001HR on Uterine Bleeding Rates in Menopausal Women with Vasomotor Symptoms. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1431-1432.

2017

Comparison of intravaginal 6.5 mg (0.50%) prasterone, 0.3 mg conjugated estrogens and 10 mu g estradiol on symptoms of vulvovaginal atrophy. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 1-8.

Full Text via DOI: 10.1016/j.jsbmb.2017.03.014 PMID: 28323042

2017

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong. CLIMACTERIC. 20:402-413.

Full Text via DOI: 10.1080/13697137.2017.1362156 PMID: 28805475

2017

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1101-1112.

Full Text via DOI: 10.1097/GME.0000000000000983 PMID: 28872490

2017

BLEEDING AND SPOTTING WITH 180 DAYS' CONTINUOUS USE OF A COMBINED NESTORONE/ESTRADIOL CONTRACEPTIVE VAGINAL RING. FERTILITY AND STERILITY. E11-E11.

2017

ELAGOLIX IMPROVES QUALITY OF LIFE IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS: EVIDENCE FROM A PHASE 2B RANDOMIZED TRIAL.. FERTILITY AND STERILITY. E27-E27.

2017

LONG-TERM EFFECT OF ELAGOLIX ON BONE MINERAL DENSITY: RESULTS FROM TWO PHASE 3 EXTENSION STUDIES IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN.. FERTILITY AND STERILITY. E95-E95.

2017

THE EFFECTS OF THE ETONOGESTREL 0.12MG/ETHINYL ESTRADIOL 0.015MG VAGINAL RING (NUVARING (R)) ON INFLAMMATORY BIOMARKERS. FERTILITY AND STERILITY. E121-E121.

2017

USE OF PEAK DRUG LEVELS TO ASSESS COMPLIANCE WITH VAGINAL RING CONTRACEPTION.. FERTILITY AND STERILITY. E12-E12.

2017

Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 24:1003-1010.

Full Text via DOI: 10.1097/GME.0000000000000880 PMID: 28419068

2017

LETTERS TO THE EDITOR Reply. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 988-989.

2017

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. NEW ENGLAND JOURNAL OF MEDICINE. 377:28-40.

Full Text via DOI: 10.1056/NEJMoa1700089 PMID: 28525302

2017

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study. FERTILITY AND STERILITY. 108:152-+.

Full Text via DOI: 10.1016/j.fertnstert.2017.05.006 PMID: 28579415

2017

Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women. JOURNAL OF WOMENS HEALTH. 26:616-623.

Full Text via DOI: 10.1089/jwh.2016.6187 PMID: 28355090

2017

A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data review. MATURITAS. 51-58.

Full Text via DOI: 10.1016/j.maturitas.2017.02.008 PMID: 28364869

2017

REPLENISH Trial: Combination Capsule of Estradiol/Progesterone (TX-001HR) for Treating Hot Flushes. OBSTETRICS AND GYNECOLOGY. 133S-134S.

Full Text via DOI: 10.1097/01.AOG.0000514678.75674.b8

2017

TX-004HR vaginal estradiol has negligible to very low systemic absorption of estradiol. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 24:510-516.

Full Text via DOI: 10.1097/GME.0000000000000790 PMID: 28002201

2017

The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 24:409-416.

Full Text via DOI: 10.1097/GME.0000000000000786 PMID: 27922936

2017

Dose-Dependent Suppression of Ovulation and Ovarian Activity by Elagolix in Healthy Premenopausal Women.. REPRODUCTIVE SCIENCES. 140A-140A.

2017

Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 24:1246-1256.

Full Text via DOI: 10.1097/GME.0000000000000910 PMID: 28640161

2017

Heavy menstrual bleeding diagnosis and medical management.

Full Text via DOI: 10.1186/s40834-017-0047-4 PMID: 29201425

2017

LETTERS TO THE EDITOR Reply. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 988-989.

Full Text via DOI: 10.1097/GME.0000000000000940 PMID: 28719419

2017

Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 24:1167-1174.

Full Text via DOI: 10.1097/GME.0000000000000900 PMID: 28509812

2017

Safety and benefit considerations for menopausal hormone therapy. EXPERT OPINION ON DRUG SAFETY. 941-954.

Full Text via DOI: 10.1080/14740338.2017.1343298 PMID: 28664754

2017

Science of intracrinology in postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 702-712.

Full Text via DOI: 10.1097/GME.0000000000000808 PMID: 28098598

2016

Significant Improvement in Vaginal Epithelium with TX-004HR in Postmenopausal Women with Moderate-to-Severe Vulvar and Vaginal Atrophy (VVA) and Dyspareunia. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1372-1372.

2016

TX-004HR Improves Vaginal Physiology and Dyspareunia with Negligible Systemic Absorption. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1371-1371.

2016

TX-004HR Provides Robust Efficacy for Symptomatic Postmenopausal Vulvar and Vaginal Atrophy (VVA) while Providing Negligible to Very Low Systemic Absorption of Estradiol: Results of Clinical Phase 2 and 3 Trials. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1374-1375.

2016

Assessment of the vaginal residence time of biomarkers of semen exposure. CONTRACEPTION. 94:512-520.

Full Text via DOI: 10.1016/j.contraception.2016.05.012 PMID: 27259675

2016

Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials. JOURNAL OF WOMENS HEALTH. 25:1102-1111.

Full Text via DOI: 10.1089/jwh.2015.5558 PMID: 27676118

2016

The Effect of Levonorgestrel on Fibrinolytic Factors in Human Endometrial Endothelial Cells. REPRODUCTIVE SCIENCES. 23:1536-1541.

Full Text via DOI: 10.1177/1933719116645193 PMID: 27130232

2016

Clinical Performance, Acceptability, and Optimization of Fast-dissolve Vaginal Inserts Designed for HIV-prevention: Results from Two Clinical Studies. AIDS RESEARCH AND HUMAN RETROVIRUSES. 53-53.

2016

Prescribing of FDA-approved and compounded hormone therapy differs by specialty. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 23:1075-1082.

Full Text via DOI: 10.1097/GME.0000000000000683 PMID: 27648594

2016

THE EFFECT OF ELAGOLIX ON BONE MINERAL DENSITY: SAFETY RESULTS FROM TWO RANDOMIZED, PLACEBO-CONTROLLED STUDIES IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN.. FERTILITY AND STERILITY. E276-E277.

2016

Activity of CYP3A4 and CYP2C19 in Young Women Who Use Depot Medroxyprogesterone Acetate (DMPA). OBSTETRICS AND GYNECOLOGY. 120S-121S.

2016

Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials. JOURNAL OF WOMENS HEALTH. 25:431-442.

Full Text via DOI: 10.1089/jwh.2015.5351 PMID: 27058301

2016

Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator. GYNECOLOGICAL ENDOCRINOLOGY. 32:240-245.

Full Text via DOI: 10.3109/09513590.2015.1110140 PMID: 26634942

2016

Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive. CONTRACEPTION. 93:52-57.

Full Text via DOI: 10.1016/j.contraception.2015.09.013 PMID: 26410176

2016

Does laryngoscopic view after intubation predict laryngoscopic view before intubation?. JOURNAL OF CLINICAL ANESTHESIA. 33:469-475.

Full Text via DOI: 10.1016/j.jclinane.2016.04.037 PMID: 27555212

2016

Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study. HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION. 25:181-190.

Full Text via DOI: 10.1515/hmbci-2015-0044 PMID: 26725467

2016

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 23:243-256.

Full Text via DOI: 10.1097/GME.0000000000000571 PMID: 26731686

2016

Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone (R) and ethinyl estradiol. CONTRACEPTION. 93:58-64.

Full Text via DOI: 10.1016/j.contraception.2015.09.008 PMID: 26408374

2016

Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical data. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 23:957-964.

Full Text via DOI: 10.1097/GME.0000000000000656 PMID: 27404027

2016

Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5 mg intravaginal prasterone for 12 weeks. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 159:142-153.

Full Text via DOI: 10.1016/j.jsbmb.2016.03.016 PMID: 26972555

2016

The effect of dalteparin on thromboelastography in pregnancy: an in vitro study. INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA. 28:22-27.

Full Text via DOI: 10.1016/j.ijoa.2016.08.002 PMID: 27717636

2016

Untitled. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 471-472.

Full Text via DOI: 10.1097/GME.0000000000000638 PMID: 26908208

2015

Effects of Ospemifene on Lipid and Coagulation Parameters in Postmenopausal Women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1375-1375.

2015

Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability. CONTRACEPTION. 92:439-444.

Full Text via DOI: 10.1016/j.contraception.2015.07.014 PMID: 26232513

2015

Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 22:1067-1075.

Full Text via DOI: 10.1097/GME.0000000000000436 PMID: 25756697

2015

ELAGOLIX FOR THE MANAGEMENT OF HEAVY MENSTRUAL BLEEDING (HMB) ASSOCIATED WITH UTERINE FIBROIDS (UF): RESULTS FROM A PHASE 2A PROOF-OF-CONCEPT STUDY. FERTILITY AND STERILITY. E70-E71.

2015

ESTRADIOL VERSUS TRANEXAMIC ACID ON THE AMOUNT AND DURATION OF ACUTE CYCLIC HEAVY MENSTRUAL BLEEDING.. FERTILITY AND STERILITY. E171-E171.

2015

Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone). MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 22:950-963.

Full Text via DOI: 10.1097/GME.0000000000000428 PMID: 25734980

2015

Insight into the biogenesis of tax nuclear speckles using comparative interactome analysis. RETROVIROLOGY.

2015

Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy. CLIMACTERIC. 18:590-607.

Full Text via DOI: 10.3109/13697137.2014.992012 PMID: 25511551

2015

Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system. EXPERT OPINION ON PHARMACOTHERAPY. 1901-1909.

Full Text via DOI: 10.1517/14656566.2015.1056733 PMID: 26194214

2015

Vaginal atrophy and disease susceptibility: the role of leukocytes. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 804-805.

Full Text via DOI: 10.1097/gme.0000000000000513 PMID: 26154272

2015

Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 786-796.

Full Text via DOI: 10.1097/GME.0000000000000365 PMID: 25423325

2015

17 beta-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review. MATURITAS. 28-35.

Full Text via DOI: 10.1016/j.maturitas.2015.02.266 PMID: 25835751

2015

A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women. CONTRACEPTION. 360-367.

Full Text via DOI: 10.1016/j.contraception.2015.01.008 PMID: 25596512

2015

Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. MATURITAS. 81:46-56.

Full Text via DOI: 10.1016/j.maturitas.2015.02.005 PMID: 25771041

2015

Prevalence of Use and Cost of Compounded Menopausal Hormone Therapy. OBSTETRICS AND GYNECOLOGY. 98S-98S.

2015

Contraceptive Efficacy, Safety, Fit, and Acceptability of a Single-Size Diaphragm Developed With End-User Input. OBSTETRICS AND GYNECOLOGY. 125:895-903.

Full Text via DOI: 10.1097/AOG.0000000000000721 PMID: 25751199

2015

Risks of Sex Hormone Therapy in Women: Important Lessons from the Transgender Woman Literature Response. SOUTHERN MEDICAL JOURNAL. 242-243.

2015

Vaginal cytokines do not correlate with postmenopausal vulvovaginal symptoms. GYNECOLOGICAL ENDOCRINOLOGY. 31:317-321.

Full Text via DOI: 10.3109/09513590.2014.995080 PMID: 25559048

2015

Impact of a One-Year Contraceptive Vaginal Ring Delivering Nestorone and Ethinyl Estradiol on Hepatic Estrogen-Sensitive Proteins. REPRODUCTIVE SCIENCES. 111A-112A.

2015

New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study. CONTRACEPTION. 91:211-216.

Full Text via DOI: 10.1016/j.contraception.2014.11.013 PMID: 25586864

2015

Recent advances help understand and improve the safety of menopausal therapies. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 351-360.

Full Text via DOI: 10.1097/gme.0000000000000292 PMID: 25051290

2015

Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 212.

Full Text via DOI: 10.1016/j.ajog.2014.09.014 PMID: 25220709

2015

Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill. CONTRACEPTION. 91:204-210.

Full Text via DOI: 10.1016/j.contraception.2014.11.011 PMID: 25582984

2015

Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 139-143.

Full Text via DOI: 10.1016/j.jsbmb.2014.09.003 PMID: 25201455

2015

Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy. JOURNAL OF SEXUAL MEDICINE. 12:2401-2412.

Full Text via DOI: 10.1111/jsm.13045 PMID: 26597311

2015

Endometrial safety of ospemifene: results of the phase 2/3 clinical development program. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 22:36-43.

Full Text via DOI: 10.1097/gme.0000000000000275 PMID: 24977459

2015

Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner. CLIMACTERIC. 18:817-825.

Full Text via DOI: 10.3109/13697137.2015.1077508 PMID: 26517756

2015

Interrelationships of Sex, Physician-Diagnosed Arthritis, Chronic Inflammation, and Physical Functioning in the Third National Health and Nutrition Examination Surveys.. GERONTOLOGY AND GERIATRIC MEDICINE. 2333721415591680.

Full Text via DOI: 10.1177/2333721415591680 PMID: 28138457

2015

Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 22:1289-1295.

Full Text via DOI: 10.1097/GME.0000000000000470 PMID: 25968836

2015

Risks of Sex Hormone Therapy in Women: Important Lessons from the Transgender Woman Literature Response. SOUTHERN MEDICAL JOURNAL. 242-243.

Full Text via DOI: 10.14423/SMJ.0000000000000271 PMID: 25871997

2015

Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 154:186-196.

Full Text via DOI: 10.1016/j.jsbmb.2015.08.016 PMID: 26291918

2015

Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA. HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION. 24:117-129.

Full Text via DOI: 10.1515/hmbci-2015-0035 PMID: 26509785

2014

Development of a Composite Measure of Product Adherence, Protocol Compliance, and Semen Exposure Using DNA and Protein Biomarkers for Topical HIV Prevention Studies. PLOS ONE. 9.

Full Text via DOI: 10.1371/journal.pone.0114368 PMID: 25489736

2014

Effect of Ospemifene on Vasomotor Symptoms in Postmenopausal Women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1359-1359.

2014

Incidence of Endometrial Spotting and Bleeding during Continuous Combined Estrogen plus Progestin Therapy in Normotensive versus Hypertensive Postmenopausal Women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1364-1364.

2014

Ospemifene Improved The Severity of Vulvar and Vaginal Atrophy Symptoms In Postmenopausal Women In Phase 3 Randomized, Placebo-Controlled Trials. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1332-1332.

2014

Responder Analysis of Ospemifene Treatment for Vulvar and Vaginal Atrophy in Postmenopausal Women in Phase 3 Randomized, Placebo-Controlled Trials. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1332-1332.

2014

Commentary on "Menopausal Hormone Treatment in Postmenopausal Women: Risks and Benefits". SOUTHERN MEDICAL JOURNAL. 696-697.

2014

Assessment of the Vaginal Residence Time of Biomarkers of Semen Exposure. AIDS RESEARCH AND HUMAN RETROVIRUSES. A172-A172.

2014

GLOBAL ENDOMETRIAL GENE EXPRESSION WITH CONTINUOUS EXPOSURE TO LEVONORGESTREL (LNG) VIA AN INTRAUTERINE SYSTEM (IUS).. FERTILITY AND STERILITY. E141-E141.

2014

LEVONORGESTREL DECREASES TISSUE PLASMINOGEN ACTIVATOR LEVELS THROUGH THE ANDROGEN RECEPTOR IN HUMAN ENDOMETRIAL ENDOTHELIAL CELLS.. FERTILITY AND STERILITY. E270-E271.

2014

Multicompartmental Pharmacokinetics of Tenofovir 1% Gel Using the BAT 24 Regimen Versus Daily and Single Pericoital Dosing. AIDS RESEARCH AND HUMAN RETROVIRUSES. A37-A37.

2014

Differential effects of menopausal therapies on the endometrium. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 21:899-908.

Full Text via DOI: 10.1097/gme.0000000000000186 PMID: 24518153

2014

Vaginal cytokines do not differ between postmenopausal women with and without symptoms of vulvovaginal irritation. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 21:840-845.

Full Text via DOI: 10.1097/gme.0000000000000179 PMID: 24398407

2014

Lack of Influence of Dyspareunia on the Beneficial Effect of Intravaginal Prasterone (Dehydroepiandrosterone, DHEA) on Sexual Dysfunction in Postmenopausal Women. JOURNAL OF SEXUAL MEDICINE. 11:1766-1785.

Full Text via DOI: 10.1111/jsm.12517 PMID: 24774442

2014

Low-Dose Levonorgestrel and Ethinyl Estradiol Patch and Pill: A Randomized Controlled Trial Reply. OBSTETRICS AND GYNECOLOGY. 1108-1108.

2014

Gestodene: A review of its pharmacology, potency and tolerability in combined contraceptive preparations. CONTRACEPTION. 242-252.

Full Text via DOI: 10.1016/j.contraception.2013.12.003 PMID: 24485094

2014

A randomized, double- blind, placebo- controlled study of the lowest effective dose of drospirenone with 17 beta- estradiol for moderate to severe vasomotor symptoms in postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 21:227-235.

Full Text via DOI: 10.1097/GME.0b013e31829c1431 PMID: 23963307

2014

COX-2, NF-kappa B, and IL-8 Expression in the Placenta in Severe Preeclampsia. REPRODUCTIVE SCIENCES. 190A-190A.

2014

Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17 beta-estradiol in postmenopausal women with moderate to severe vasomotor symptoms. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 21:236-242.

Full Text via DOI: 10.1097/GME.0b013e31829c12e8 PMID: 23963309

2014

Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 99:E189-E198.

Full Text via DOI: 10.1210/jc.2013-1707 PMID: 24438370

2014

Low-Dose Levonorgestrel and Ethinyl Estradiol Patch and Pill A Randomized Controlled Trial. OBSTETRICS AND GYNECOLOGY. 123:295-303.

Full Text via DOI: 10.1097/AOG.0000000000000095 PMID: 24402597

2014

RE: Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE.

Full Text via DOI: 10.1093/jnci/djt372 PMID: 24363446

2014

Commentary on "Menopausal Hormone Treatment in Postmenopausal Women: Risks and Benefits". SOUTHERN MEDICAL JOURNAL. 696-697.

Full Text via DOI: 10.14423/SMJ.0000000000000191 PMID: 25365436

2014

Low-Dose Levonorgestrel and Ethinyl Estradiol Patch and Pill: A Randomized Controlled Trial Reply. OBSTETRICS AND GYNECOLOGY. 1108-1108.

Full Text via DOI: 10.1097/AOG.0000000000000248 PMID: 24785870

2014

Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm. CONTRACEPTION. 89:31-35.

Full Text via DOI: 10.1016/j.contraception.2013.07.002 PMID: 23993431

2013

Safety of Oral Ospemifene in Phase 2/3 Placebo-controlled Clinical Trials. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1322-1322.

2013

Vaginal and systemic cytokines in postmenopausal women with and without symptoms of vulvovaginal irritation. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1332-1332.

2013

Toward Early Safety Alert Endpoints: Exploring Biomarkers Suggestive of Microbicide Failure. AIDS RESEARCH AND HUMAN RETROVIRUSES. 29:1475-1486.

Full Text via DOI: 10.1089/aid.2012.0345 PMID: 23885658

2013

A statement on abortion by 100A professors of obstetrics: 40 years later. CONTRACEPTION. 88:568-576.

Full Text via DOI: 10.1016/j.contraception.2013.07.003 PMID: 24034806

2013

A statement on abortion by 100 professors of obstetrics: 40 years later. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 193-199.

Full Text via DOI: 10.1016/j.ajog.2013.03.007 PMID: 23500455

2013

Norethindrone Acetate 1.0 Milligram and Ethinyl Estradiol 10 Micrograms as an Ultra Low-Dose Oral Contraceptive. OBSTETRICS AND GYNECOLOGY. 122:601-607.

Full Text via DOI: 10.1097/AOG.0b013e3182a1741c PMID: 23921878

2013

PROSTAGLANDIN F2 ALPHA IS A PRODUCT OF THE DECIDUALIZED HUMAN STROMAL CELL.. FERTILITY AND STERILITY. S298-S298.

2013

Reproductive history and postmenopausal rheumatoid arthritis among women 60 years or older: Third National Health and Nutrition Examination Survey. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 20:930-935.

Full Text via DOI: 10.1097/gme.0b013e3182a14372 PMID: 23942247

2013

TSPY4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in HIV prevention and contraception studies. CONTRACEPTION. 88:387-395.

Full Text via DOI: 10.1016/j.contraception.2012.11.022 PMID: 23312930

2013

EFFECTS OF MELOXICAM, A SEMI-SELECTIVE CYCLO-OXYGENASE 2 (COX-2) INHIBITOR, ON THE ULTRASOUND APPEARANCE OF THE DOMINANT FOLLICLE BEFORE AND AFTER THE LUTEINIZING HORMONE (LH) SURGE. CONTRACEPTION. 312-312.

2013

Ethinyl estradiol and 17 beta-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. CONTRACEPTION. 706-727.

Full Text via DOI: 10.1016/j.contraception.2012.12.011 PMID: 23375353

2013

Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics. CONTRACEPTION. 87:738-743.

Full Text via DOI: 10.1016/j.contraception.2012.11.010 PMID: 23265980

2013

The importance of pharmacokinetic studies in drug development. CONTRACEPTION. 701-702.

Full Text via DOI: 10.1016/j.contraception.2013.04.004 PMID: 23668376

2013

Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch. CONTRACEPTION. 87:744-749.

Full Text via DOI: 10.1016/j.contraception.2012.10.038 PMID: 23228503

2013

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. CLIMACTERIC. 16:316-337.

Full Text via DOI: 10.3109/13697137.2013.795683 PMID: 23672656

2013

Weight gain during the menopause transition: which comes first, the chicken or the egg?. CLIMACTERIC. 296-297.

2013

Role of COX-2 in Decidualization of Endometrial Stromal Cells. REPRODUCTIVE SCIENCES. 228A-229A.

2013

Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms. CLIMACTERIC. 16:17-27.

Full Text via DOI: 10.3109/13697137.2012.672495 PMID: 22646219

2013

Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel. CONTRACEPTION. 87:201-211.

Full Text via DOI: 10.1016/j.contraception.2012.08.042 PMID: 23036478

2013

Pharmacokinetics and adhesion of the Agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity and exercise. CONTRACEPTION. 87:212-219.

Full Text via DOI: 10.1016/j.contraception.2012.10.009 PMID: 23158806

2013

Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 20:47-56.

Full Text via DOI: 10.1097/gme.0b013e3182775fe9 PMID: 23266840

2013

Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 20:38-46.

Full Text via DOI: 10.1097/GME.0b013e318274699f PMID: 23266839

2013

Soil Diversity and Hydration as Observed by ChemCam at Gale Crater, Mars. SCIENCE. 341.

Full Text via DOI: 10.1126/science.1238670 PMID: 24072924

2012

Postmenopausal skin and estrogen. GYNECOLOGICAL ENDOCRINOLOGY. 2-6.

Full Text via DOI: 10.3109/09513590.2012.705392 PMID: 22849791

2012

SAFETY AND TOLERABILITY OF THE AGILE PATCH, A CONTRACEPTIVE PATCH WITH LOW-DOSE ETHINYL ESTRADIOL (EE) AND LEVONORGESTREL (LNG), VS. COMBINATION ORAL CONTRACEPTIVES (COCS) IN OBESE VS. NON-OBESE WOMEN. FERTILITY AND STERILITY. S195-S196.

2012

Vascular dysfunction as a cause of endometrial bleeding. GYNECOLOGICAL ENDOCRINOLOGY. 28:688-693.

Full Text via DOI: 10.3109/09513590.2011.588848 PMID: 22686262

2012

The use of isoflavinoids in menopausal health Reply. CLIMACTERIC. 407-408.

2012

Estrogen and progestogen effect on venous thromboembolism in menopausal women. CLIMACTERIC. 235-240.

Full Text via DOI: 10.3109/13697137.2012.664401 PMID: 22612609

2012

Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial. CONTRACEPTION. 85:595-601.

Full Text via DOI: 10.1016/j.contraception.2011.10.006 PMID: 22133660

2012

Transdermal estradiol gel for the treatment of symptomatic postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 19:622-629.

Full Text via DOI: 10.1097/gme.0b013e31823b8867 PMID: 22282101

2012

Differential Pathways of Hemostasis and Fibrinolysis in Human Endometrial Endothelial Cells. REPRODUCTIVE SCIENCES. 228A-228A.

2012

SERUM ETHINYL ESTRADIOL LEVELS WITH A LOW-DOSE COMBINATION TRANSDERMAL CONTRACEPTIVE (AG200-15) COMPARED WITH A LOW-DOSE COMBINATION ORAL CONTRACEPTIVE. CONTRACEPTION. 318-318.

2011

Cardiovascular, Cerebrovascular and Hepatic Safety of Desvenlafaxine Over 1 Year in Women With Vasomotor Symptoms Associated With Menopause. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1348-1348.

2011

Is There Ever an Indication for Hormone Therapy in an Asymptomatic Postmenopausal Woman?. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1339-1339.

2011

One-year Maintenance of Efficacy and Safety of Desvenlafaxine in Women With Vasomotor Symptoms Associated With Menopause. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1367-1367.

2011

Safety and Tolerability of Bazedoxifene/Conjugated Estrogens in Postmenopausal Women: Findings From a 1-Year, Randomized, Placebo- and Active-controlled, Phase 3 Trial. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1355-1356.

2011

Transdermal estradiol gel for the treatment of symptomatic postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1355-1355.

2011

Delivery of therapeutic agents to the target tissue. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1040-1041.

Full Text via DOI: 10.1097/gme.0b013e31822ff238 PMID: 21926921

2011

Menopausal hot flushes and night sweats: where are we now?. CLIMACTERIC. 515-528.

Full Text via DOI: 10.3109/13697137.2011.608596 PMID: 21848495

2011

THYROID STIMULATING HORMONE (TSH) RECEPTOR ON GRANULOSA CELLS. FERTILITY AND STERILITY. S118-S118.

2011

TOLERABILITY OF DESVENLAFAXINE 100 MG IN WOMEN WITH VASOMOTOR SYMPTOMS (VMS) ASSOCIATED WITH MENOPAUSE: A POOLED ANALYSIS OF 5 TRIALS. FERTILITY AND STERILITY. S4-S5.

2011

Endogenous androgens and effects on body fat and insulin resistance. CLIMACTERIC. 405-406.

2011

Tailoring Combination Oral Contraceptives to the Individual Woman. JOURNAL OF WOMENS HEALTH. 20:879-891.

Full Text via DOI: 10.1089/jwh.2010.2199 PMID: 21631372

2011

Endometrial bleeding in postmenopausal women: with and without hormone therapy. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 18:416-420.

Full Text via DOI: 10.1097/gme.0b013e31820ca808 PMID: 21701426

2011

Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia. CLIMACTERIC. 14:282-288.

Full Text via DOI: 10.3109/13697137.2010.535226 PMID: 21244215

2011

Endogenous androgens and effects on body fat and insulin resistance. CLIMACTERIC. 405-406.

PMID: 21721175

2011

The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 6-7.

Full Text via DOI: 10.1097/gme.0b013e318203a46b PMID: 21173718

2011

Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. CLIMACTERIC. 14:302-320.

Full Text via DOI: 10.3109/13697137.2011.570590 PMID: 21563996

2010

Contraceptive Efficacy, Acceptability, and Safety of C31G and Nonoxynol-9 Spermicidal Gels A Randomized Controlled Trial. OBSTETRICS AND GYNECOLOGY. 116:1265-1273.

Full Text via DOI: 10.1097/AOG.0b013e3181fc3b1a PMID: 21099590

2010

High efficacy of intravaginal DHEA on vaginal atrophy in postmenopausal women having identified pain at intercourse (dyspareunia) as their most bothersome symptom. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1232-1233.

2010

Vaginal cytokines in postmenopausal women with symptoms of vulvovaginal irritation. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1243-1243.

2010

EVALUATION OF EXPOSURE TO ETHINYL ESTRADIOL (EE) WITH A LOW DOSE COMBINATION TRANSDERMAL CONTRACEPTIVE DELIVERY SYSTEM (AG200-15) COMPARED TO LOW-DOSE COMBINATION ORAL CONTRACEPTIVE.. FERTILITY AND STERILITY. S4-S5.

2010

High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy. GYNECOLOGICAL ENDOCRINOLOGY. 26:524-532.

Full Text via DOI: 10.3109/09513590903511547 PMID: 20459349

2010

Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 95:S7-+.

Full Text via DOI: 10.1210/jc.2009-2509 PMID: 20566620

2010

A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 454-455.

Full Text via DOI: 10.1097/gme.0b013e3181dbf241 PMID: 20386342

2010

Desvenlafaxine: A therapeutic option for treatment of menopausal hot flashes. MATURITAS. 1-2.

Full Text via DOI: 10.1016/j.maturitas.2010.02.007 PMID: 20211532

2010

Levonorgestrel effects on serum androgens, sex hormone-binding globulin levels, hair shaft diameter, and sexual function. FERTILITY AND STERILITY. 93:1997-2003.

Full Text via DOI: 10.1016/j.fertnstert.2008.12.095 PMID: 19394598

2010

Beneficial effect of intravaginal DHEA in postmenopausal women suffering from vaginal atrophy and having identified pain at intercourse (dyspareunia) as their most bothersome symptom. ENDOCRINE JOURNAL. S526-S526.

2010

High efficacy of intravaginal DHEA on all symptoms and signs of vaginal atrophy. ENDOCRINE JOURNAL. S527-S527.

2010

Effect of intravaginal DHEA in postmenopausal women with vaginal atrophy and pain at sexual activity (dyspareunia) as most bothersome symptom. 13TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI) HELD JOINTLY WITH THE GERMAN SOCIETY OF OBSTETRICS & GYNECOLOGY. 233-238.

2010

Efficacy and tolerability of local estrogen therapy for urogenital atrophy. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 194-203.

Full Text via DOI: 10.1097/gme.0b013e3181a95581 PMID: 19602990

2010

Tissue-Selective Estrogen Complexes A Promising Option for the Comprehensive Management of Menopausal Symptoms. DRUGS & AGING. 533-544.

Full Text via DOI: 10.2165/11316000-000000000-00000 PMID: 20583848

2010

Tissue-Selective Estrogen Complexes A Promising Option for the Comprehensive Management of Menopausal Symptoms. DRUGS & AGING. 533-544.

2009

Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 16:1102-1108.

Full Text via DOI: 10.1097/gme.0b013e3181a816be PMID: 19546825

2009

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 16:1109-1115.

Full Text via DOI: 10.1097/gme.0b013e3181a818db PMID: 19543129

2009

Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women. FERTILITY AND STERILITY. 92:1039-1044.

Full Text via DOI: 10.1016/j.fertnstert.2009.05.093 PMID: 19635614

2009

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 16:923-931.

Full Text via DOI: 10.1097/gme.0b013e31819e85c6 PMID: 19424093

2009

Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 16:907-922.

Full Text via DOI: 10.1097/gme.0b013e31819e8e2d PMID: 19436225

2009

Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen. CONTRACEPTION. 80:245-253.

Full Text via DOI: 10.1016/j.contraception.2009.03.006 PMID: 19698816

2009

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 16:897-906.

Full Text via DOI: 10.1097/gme.0b013e31819e8930 PMID: 19436226

2009

Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant. CONTRACEPTION. 79:469-478.

Full Text via DOI: 10.1016/j.contraception.2008.12.010 PMID: 19442784

2009

Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 200.

Full Text via DOI: 10.1016/j.ajog.2008.10.057 PMID: 19167693

2009

A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 200.

Full Text via DOI: 10.1016/j.ajog.2008.09.877 PMID: 19110224

2009

Effects of progesterone, levonorgestrel and medroxyprogesterone acetate on apoptosis in human endometrial endothelial cells. CONTRACEPTION. 79:139-145.

Full Text via DOI: 10.1016/j.contraception.2008.08.008 PMID: 19135572

2009

Menopausal hot flashes are treated effectively by a transdermal, low-dose estradiol spray. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM. 18-19.

Full Text via DOI: 10.1038/ncpendmet1024 PMID: 19079270

2009

Premature menopause increases cardiovascular risk. CLIMACTERIC. 12:26-31.

Full Text via DOI: 10.1080/13697130903013452 PMID: 19811237

2008

Intravaginal DHEA, the Physiological and Highly Efficient Treatment of Vaginal Atrophy. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1230-1230.

2008

Tailoring Progestogen Therapy for the Individual Patient. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1201-1201.

2008

Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users. CONTRACEPTION. 78:106-112.

Full Text via DOI: 10.1016/j.contraception.2008.04.003 PMID: 18672110

2008

Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 584-602.

Full Text via DOI: 10.1097/gme.0b013e31817b076a PMID: 18580541

2008

Effects of estradiol on synthesis, secretion, and activation of von Willebrand factor in endometrial endothelial cell. REPRODUCTIVE SCIENCES. 283A-283A.

2008

Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 198.

Full Text via DOI: 10.1016/j.ajog.2007.05.020 PMID: 18166301

2008

Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women. CLIMACTERIC. 11:63-73.

Full Text via DOI: 10.1080/13697130701852390 PMID: 18202966

2007

Clinical outcomes associated with new oral low-dose EPT. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 1080-1080.

2007

Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women. FERTILITY AND STERILITY. 88:866-878.

Full Text via DOI: 10.1016/j.fertnstert.2006.12.052 PMID: 17548089

2007

Analysis of characteristics of women with early amenorrhea or persistent unscheduled bleeding with cycle-free LNG/EE, a continuous-use oral contraceptive (OC).. FERTILITY AND STERILITY. S256-S256.

2007

Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm - A randomized controlled trial. OBSTETRICS AND GYNECOLOGY. 110:577-586.

2007

Desvenlafaxine succinate (DVS) efficacy for the relief of vasomotor symptoms (VMS) associated with menopause: A double-blind, placebo-controlled trial.. FERTILITY AND STERILITY. S243-S243.

2007

Desvenlafaxine succinate (DVS), a novel serotonin and norepinephrine reuptake inhibitor, improves mood and menopausal symptoms in women with hot flushes (HFS) associated with menopause.. FERTILITY AND STERILITY. S246-S246.

2007

Effect of vascular endothelial growth factor (VEGF) withdrawal on apoptosis in an immortalized human endometrial endothelial cell (HEEC) line.. FERTILITY AND STERILITY. S51-S52.

2007

Endometrial and ovarian safety of bazedoxifene (BZA) in the prevention of postmenopausal osteoporosis.. FERTILITY AND STERILITY. S241-S242.

2007

Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-at mRNA in Ishikawa cells implication for tibolone's effects on the endometrium. MATURITAS. 57:338-346.

Full Text via DOI: 10.1016/j.maturitas.2007.03.002 PMID: 17478063

2007

Endometrial bleeding during hormone therapy: The effect of progestogens. MATURITAS. 57:71-76.

Full Text via DOI: 10.1016/j.maturitas.2007.02.022 PMID: 17412535

2007

Drospirenone, a progestin with added value for hypertensive postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 352-354.

Full Text via DOI: 10.1097/gme.0b013e31804d440b PMID: 17414576

2007

Desvenlafaxine succinate is effective in the treatment of menopausal vasomotor symptoms. OBSTETRICS AND GYNECOLOGY. 76S-77S.

2007

Effects of desvenlafaxine on sleep and mood in menopausal women - A pooled analysis. OBSTETRICS AND GYNECOLOGY. 77S-77S.

2007

Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. CLIMACTERIC. 10:120-131.

Full Text via DOI: 10.1080/13697130701298107 PMID: 17453860

2007

Endometrial effects of tibolone. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 92:911-918.

Full Text via DOI: 10.1210/jc.2006-2207 PMID: 17192288

2007

Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 168-182.

Full Text via DOI: 10.1097/gme.0b013e31803167ab PMID: 17259911

2007

Drospirenone and estradiol: a new option for the postmenopausal woman. CLIMACTERIC. 10:3-10.

Full Text via DOI: 10.1080/13697130601114859 PMID: 17364592

2007

Drospirenone-containing hormone therapy for postmenopausal women - Perspective on current data. JOURNAL OF REPRODUCTIVE MEDICINE. 52:159-164.

2007

Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy. HUMAN REPRODUCTION. 22:427-433.

Full Text via DOI: 10.1093/humrep/de1398

2007

The role of aldosterone in progression of hypertension - How it affects women in menopause. JOURNAL OF REPRODUCTIVE MEDICINE. 143-146.

2007

Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 mu g (Loestrin (R) 24 Fe). CONTRACEPTION. 75:16-22.

Full Text via DOI: 10.1016/j.contraception.2006.08.004 PMID: 17161118

2007

Medical decisions regarding hormone therapy for menopausal women are significantly influenced by the media. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 28-31.

Full Text via DOI: 10.1002/pds.1342 PMID: 17177322

2006

Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. CONTRACEPTION. 74:439-445.

Full Text via DOI: 10.1016/j.contraception.2006.07.005 PMID: 17157099

2006

Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives. CONTRACEPTION. 359-366.

Full Text via DOI: 10.1016/j.contraception.2006.06.003 PMID: 17046376

2006

Progesterone receptor modulator for emergency contraception - A randomized controlled trial. OBSTETRICS AND GYNECOLOGY. 108:1089-1097.

2006

FemCap (TM) with removal strap: ease of removal, safety and acceptability. CONTRACEPTION. 73:59-64.

Full Text via DOI: 10.1016/j.contraception.2005.06.074 PMID: 16371297

2005

Microarray analysis of genes related with angiogenesis in human endometrial cells trated with delta 4-tibolone and medroxyprogesterone acetate. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 786-786.

2005

Interleukin-1 beta,-2,-6, and -8 levels in serum and uterine cavity fluid during the normal luteal phase.. FERTILITY AND STERILITY. S26-S26.

2005

Progestogens: effects on clinical and biochemical parameters in postmenopausal women. MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY. 484-487.

Full Text via DOI: 10.1097/01.gme.0000177319.31629.52 PMID: 16145299

2005

Raloxifene (Rix) effects on vascular endothelial growth factor (VEGF) and thrombospondin-1 (TSP-1) are not mediated by changes in steroid receptor (SR) co-repressors or co-activators or cell proliferation markers in a human endometrial cell line.. FERTILITY AND STERILITY. S230-S230.

2005

Raloxifene (Rix) has antiestrogenic effect on vascular endothelial growth factor (VEGF) mRNA and protein while down-regulating progesterone receptors in a human endometrial cell line in vitro.. FERTILITY AND STERILITY. S229-S230.

2005

Raloxifene shows progestagenic effects on thrombospondin-1 (TSP-1) and down-regulation of progesterone receptors in a human endometrial cell line.. FERTILITY AND STERILITY. S119-S120.

2005

Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells. FERTILITY AND STERILITY. 84:485-491.

Full Text via DOI: 10.1016/j.fertnstert.2005.01.129 PMID: 16084894

2005

Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women. OBSTETRICS AND GYNECOLOGY. 105:1397-1404.

Full Text via DOI: 10.1097/01.AOG.0000163253.27610.b9 PMID: 15932835

2005

A contemporary approach to the menopause - Preface. SEMINARS IN REPRODUCTIVE MEDICINE. 115-116.

2005

Lower doses of oral estrogen and progestogens as treatment for postmenopausal women. SEMINARS IN REPRODUCTIVE MEDICINE. 23:188-195.

2005

Safety and efficacy of Implanon (TM), a single-rod implantable contraceptive containing etonogestrel. CONTRACEPTION. 71:319-326.

Full Text via DOI: 10.1016/j.contraception.2004.11.007 PMID: 15854630

2005

Doxycycline alters the expression profile of proinflammatory cytokines and chemokines in human endometrial cells.. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION. 168A-168A.

Researchers@EVMS

Archer, David F.
Close

Contact Info

Publications

selected publications

Research

principal investigator on

Contact

full name

visualizations

research areas